UniProt ID | LYAG_HUMAN | |
---|---|---|
UniProt AC | P10253 | |
Protein Name | Lysosomal alpha-glucosidase | |
Gene Name | GAA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 952 | |
Subcellular Localization | Lysosome . Lysosome membrane . | |
Protein Description | Essential for the degradation of glycogen in lysosomes. [PubMed: 1856189] | |
Protein Sequence | MGVRHPPCSHRLLAVCALVSLATAALLGHILLHDFLLVPRELSGSSPVLEETHPAHQQGASRPGPRDAQAHPGRPRAVPTQCDVPPNSRFDCAPDKAITQEQCEARGCCYIPAKQGLQGAQMGQPWCFFPPSYPSYKLENLSSSEMGYTATLTRTTPTFFPKDILTLRLDVMMETENRLHFTIKDPANRRYEVPLETPHVHSRAPSPLYSVEFSEEPFGVIVRRQLDGRVLLNTTVAPLFFADQFLQLSTSLPSQYITGLAEHLSPLMLSTSWTRITLWNRDLAPTPGANLYGSHPFYLALEDGGSAHGVFLLNSNAMDVVLQPSPALSWRSTGGILDVYIFLGPEPKSVVQQYLDVVGYPFMPPYWGLGFHLCRWGYSSTAITRQVVENMTRAHFPLDVQWNDLDYMDSRRDFTFNKDGFRDFPAMVQELHQGGRRYMMIVDPAISSSGPAGSYRPYDEGLRRGVFITNETGQPLIGKVWPGSTAFPDFTNPTALAWWEDMVAEFHDQVPFDGMWIDMNEPSNFIRGSEDGCPNNELENPPYVPGVVGGTLQAATICASSHQFLSTHYNLHNLYGLTEAIASHRALVKARGTRPFVISRSTFAGHGRYAGHWTGDVWSSWEQLASSVPEILQFNLLGVPLVGADVCGFLGNTSEELCVRWTQLGAFYPFMRNHNSLLSLPQEPYSFSEPAQQAMRKALTLRYALLPHLYTLFHQAHVAGETVARPLFLEFPKDSSTWTVDHQLLWGEALLITPVLQAGKAEVTGYFPLGTWYDLQTVPVEALGSLPPPPAAPREPAIHSEGQWVTLPAPLDTINVHLRAGYIIPLQGPGLTTTESRQQPMALAVALTKGGEARGELFWDDGESLEVLERGAYTQVIFLARNNTIVNELVRVTSEGAGLQLQKVTVLGVATAPQQVLSNGVPVSNFTYSPDTKVLDICVSLLMGEQFLVSWC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
46 | O-linked_Glycosylation | PRELSGSSPVLEETH CHHHCCCCCCCCCCC | 23.66 | 55823813 | |
52 | O-linked_Glycosylation | SSPVLEETHPAHQQG CCCCCCCCCHHHHCC | 24.63 | 55823819 | |
61 | O-linked_Glycosylation | PAHQQGASRPGPRDA HHHHCCCCCCCCCCC | 45.92 | 55823825 | |
96 | 2-Hydroxyisobutyrylation | RFDCAPDKAITQEQC CCCCCCCCCCCHHHH | 40.40 | - | |
140 | N-linked_Glycosylation | YPSYKLENLSSSEMG CCCCCCCCCCCCCCC | 56.51 | 29061980 | |
140 | N-linked_Glycosylation | YPSYKLENLSSSEMG CCCCCCCCCCCCCCC | 56.51 | 29061980 | |
142 | Phosphorylation | SYKLENLSSSEMGYT CCCCCCCCCCCCCCE | 43.32 | 21406692 | |
142 | O-linked_Glycosylation | SYKLENLSSSEMGYT CCCCCCCCCCCCCCE | 43.32 | 32574038 | |
143 | Phosphorylation | YKLENLSSSEMGYTA CCCCCCCCCCCCCEE | 33.22 | 21406692 | |
144 | Phosphorylation | KLENLSSSEMGYTAT CCCCCCCCCCCCEEE | 28.38 | 21406692 | |
144 | O-linked_Glycosylation | KLENLSSSEMGYTAT CCCCCCCCCCCCEEE | 28.38 | 32574038 | |
148 | Phosphorylation | LSSSEMGYTATLTRT CCCCCCCCEEEEEEC | 7.59 | 21406692 | |
149 | O-linked_Glycosylation | SSSEMGYTATLTRTT CCCCCCCEEEEEECC | 13.87 | 32574038 | |
149 | Phosphorylation | SSSEMGYTATLTRTT CCCCCCCEEEEEECC | 13.87 | 21406692 | |
151 | Phosphorylation | SEMGYTATLTRTTPT CCCCCEEEEEECCCC | 22.36 | 21406692 | |
153 | Phosphorylation | MGYTATLTRTTPTFF CCCEEEEEECCCCCC | 22.93 | 21406692 | |
162 | 2-Hydroxyisobutyrylation | TTPTFFPKDILTLRL CCCCCCCHHHEEEEE | 52.85 | - | |
162 | Ubiquitination | TTPTFFPKDILTLRL CCCCCCCHHHEEEEE | 52.85 | - | |
166 | Phosphorylation | FFPKDILTLRLDVMM CCCHHHEEEEEEEEE | 15.34 | 21406692 | |
172 | Sulfoxidation | LTLRLDVMMETENRL EEEEEEEEEECCCEE | 1.68 | 30846556 | |
173 | Sulfoxidation | TLRLDVMMETENRLH EEEEEEEEECCCEEE | 6.07 | 30846556 | |
175 | Phosphorylation | RLDVMMETENRLHFT EEEEEEECCCEEEEE | 22.21 | 21406692 | |
182 | Phosphorylation | TENRLHFTIKDPANR CCCEEEEEECCCCCC | 19.17 | 21406692 | |
233 | N-linked_Glycosylation | LDGRVLLNTTVAPLF CCCEEEEECCCHHHH | 29.55 | 29061980 | |
235 | Phosphorylation | GRVLLNTTVAPLFFA CEEEEECCCHHHHCH | 17.38 | - | |
329 | Phosphorylation | LQPSPALSWRSTGGI ECCCCCCCCCCCCCE | 23.66 | 24719451 | |
390 | N-linked_Glycosylation | ITRQVVENMTRAHFP HHHHHHHHCHHCCCC | 26.05 | 29061980 | |
407 | Phosphorylation | VQWNDLDYMDSRRDF CCCCCCCCCCCCCCC | 15.32 | - | |
415 | Phosphorylation | MDSRRDFTFNKDGFR CCCCCCCCCCCCCCC | 30.50 | - | |
418 | Ubiquitination | RRDFTFNKDGFRDFP CCCCCCCCCCCCCHH | 55.85 | 33845483 | |
418 | 2-Hydroxyisobutyrylation | RRDFTFNKDGFRDFP CCCCCCCCCCCCCHH | 55.85 | - | |
438 | Phosphorylation | LHQGGRRYMMIVDPA HHHCCCEEEEEECHH | 6.95 | 28857561 | |
447 | Phosphorylation | MIVDPAISSSGPAGS EEECHHHCCCCCCCC | 22.13 | 22210691 | |
448 | Phosphorylation | IVDPAISSSGPAGSY EECHHHCCCCCCCCC | 32.95 | 22210691 | |
449 | Phosphorylation | VDPAISSSGPAGSYR ECHHHCCCCCCCCCC | 41.84 | 22210691 | |
454 | Phosphorylation | SSSGPAGSYRPYDEG CCCCCCCCCCCCCCC | 21.78 | 22210691 | |
458 | Phosphorylation | PAGSYRPYDEGLRRG CCCCCCCCCCCCCCC | 20.03 | 28857561 | |
470 | N-linked_Glycosylation | RRGVFITNETGQPLI CCCEEEECCCCCCCC | 39.76 | 29061980 | |
470 | N-linked_Glycosylation | RRGVFITNETGQPLI CCCEEEECCCCCCCC | 39.76 | 29061980 | |
589 | Ubiquitination | ASHRALVKARGTRPF HHCHHHHHHCCCCCE | 32.96 | 27667366 | |
652 | N-linked_Glycosylation | DVCGFLGNTSEELCV EECCCCCCCCHHHHH | 42.45 | 29061980 | |
676 | Phosphorylation | PFMRNHNSLLSLPQE HHHCCCCCHHCCCCC | 24.12 | 27251275 | |
679 | Phosphorylation | RNHNSLLSLPQEPYS CCCCCHHCCCCCCCC | 43.21 | 27251275 | |
722 | Phosphorylation | QAHVAGETVARPLFL HHHHCCCCCCEEEEE | 20.67 | 20071362 | |
822 | Phosphorylation | NVHLRAGYIIPLQGP EEEEECCEEEECCCC | 8.49 | 28152594 | |
849 | Ubiquitination | ALAVALTKGGEARGE EEEHHHHCCCCCCCE | 66.81 | 24816145 | |
882 | N-linked_Glycosylation | QVIFLARNNTIVNEL EEEEEECCCHHHHHH | 44.37 | 29061980 | |
884 | O-linked_Glycosylation | IFLARNNTIVNELVR EEEECCCHHHHHHHH | 29.83 | 32574038 | |
884 | Phosphorylation | IFLARNNTIVNELVR EEEECCCHHHHHHHH | 29.83 | - | |
894 | Phosphorylation | NELVRVTSEGAGLQL HHHHHHHCCCCCCEE | 31.04 | - | |
925 | N-linked_Glycosylation | SNGVPVSNFTYSPDT HCCCCCCCCCCCCCC | 33.25 | 8435067 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LYAG_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LYAG_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LYAG_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ZEP1_HUMAN | HIVEP1 | physical | 21988832 | |
STAT2_HUMAN | STAT2 | physical | 21988832 | |
NUMBL_HUMAN | NUMBL | physical | 21988832 | |
ESTD_HUMAN | ESD | physical | 26344197 | |
AATC_HUMAN | GOT1 | physical | 26344197 | |
MPPA_HUMAN | PMPCA | physical | 26344197 | |
LRC24_HUMAN | LRRC24 | physical | 28514442 | |
DYR2_HUMAN | DHFRL1 | physical | 28514442 | |
B4GN3_HUMAN | B4GALNT3 | physical | 28514442 | |
MANEL_HUMAN | MANEAL | physical | 28514442 | |
T132A_HUMAN | TMEM132A | physical | 28514442 | |
B4GT7_HUMAN | B4GALT7 | physical | 28514442 | |
EXT1_HUMAN | EXT1 | physical | 28514442 | |
ENTP7_HUMAN | ENTPD7 | physical | 28514442 | |
MA2A2_HUMAN | MAN2A2 | physical | 28514442 | |
GALT4_HUMAN | GALNT4 | physical | 28514442 | |
TM39A_HUMAN | TMEM39A | physical | 28514442 | |
B3GA3_HUMAN | B3GAT3 | physical | 28514442 | |
B4GT1_HUMAN | B4GALT1 | physical | 28514442 | |
LARG1_HUMAN | LARGE | physical | 28514442 | |
AMD_HUMAN | PAM | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00069 | Glycogen storage diseases (GSD), including: von Gierke disease (GSD type Ia); Pompe disease (GSD typ | |||||
OMIM Disease | ||||||
232300 | Glycogen storage disease 2 (GSD2) | |||||
Kegg Drug | ||||||
D00216 | Acarbose (JAN/USAN/INN); Precose (TN) | |||||
D00625 | Miglitol (JAN/USAN/INN); Glyset (TN) | |||||
D01665 | Voglibose (JP16/USAN/INN); Basen (TN) | |||||
D03207 | Alglucosidase alfa (genetical recombination) (JAN); Alglucosidase alfa (USAN/INN); Lumizyme (TN); My | |||||
D09605 | Duvoglustat (USAN/INN); 1-Deoxynojirimycin | |||||
D09606 | Duvoglustat hydrochloride (USAN) | |||||
D09779 | Emiglitate (JAN/INN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-140; ASN-470; ASN-882 ANDASN-925, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-390, AND MASSSPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-470. | |
"Human lysosomal alpha-glucosidase: functional characterization of theglycosylation sites."; Hermans M.M.P., Wisselaar H.A., Kroos M.A., Oostra B.A.,Reuser A.J.J.; Biochem. J. 289:681-686(1993). Cited for: GLYCOSYLATION AT ASN-140; ASN-233; ASN-390; ASN-470; ASN-652; ASN-882AND ASN-925. |